Key facts
- This page summarizes Mats Wahlstrom's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 11 Feb 2025, 17:59.
Mats Wahlstrom - 10 Feb 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- TLSI
- Reported as of
- 10 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Feb 2025, 17:59:14 UTC
- Prior SEC filing
- 19 Dec 2024
- Next SEC filing
- 28 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sean Murphy, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mats Wahlstrom filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 11 Feb 2025.
Change
- Previous filing in this sequence was filed on 19 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TLSI
transaction
Derivative
Series A Convertible Preferred Stock
Other
- Transaction value
- $0
- Shares
- +44,750
- Change %
- +90%
- Price
- $0.000000
- Shares after
- 94,750
- Date
- 10 Feb 2025
- Ownership
- By Leonard Capital LLC
- Underlying class
- Common Stock
- Underlying amount
- 44,750
- Exercise price
- $5.28
- Footnotes
- F1, F2, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The conversion price (the "Conversion Price") reflects the reset effective as of February 10, 2025, which reset occurred in accordance with the terms of the Issuer's Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of the Issuer filed with the Delaware Secretary of State on August 10, 2023.
Footnote F2
Effective February 10, 2025, the Conversion Price of the 50,000 shares of Series A Convertible Preferred Stock (the "Preferred Stock") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock.
Footnote F3
After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 94,750 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election.
Footnote F4
All then outstanding shares of Preferred Stock are automatically converted into shares of the Issuer's Common Stock on August 10, 2027.
Footnote F5
Represents the incremental number of shares of Common Stock that are issuable upon conversion of the Preferred Stock as a result of the Conversion Price reset.
Footnote F6
The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.